[Form 4] Delek US Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Delek US Holdings (DK)17,000 shares of common stock at a weighted average price of $41.42 and 10,000 shares at a weighted average price of $41.25. Following these sales, the reporting person beneficially owns 23,020 shares, held directly.

The filing notes the trades were executed under a Rule 10b5-1 trading plan adopted on March 6, 2025 and amended August 13, 2025. Price ranges were disclosed: $41.39–$41.59 for the first set and $41.16–$41.37 for the second.

11/13/2025 - 09:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Spiegel Reuven

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Special Projects

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		S		17,000	D	$41.42(1)	33,020	D
Common Stock	11/11/2025		S		10,000(2)	D	$41.25(3)	23,020	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $41.39 per share to a high sale price of $41.59 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.

2. This transaction was made pursuant to a 10b5-1 plan adopted on March 6, 2025, as amended August 13, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

3. The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $41.16 per share to a high sale price of $41.37 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.

Remarks:

	/s/ Reuven Spiegel	11/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DK disclose in this Form 4?

An EVP, Special Projects reported selling 17,000 and 10,000 DK common shares on 11/11/2025.

At what prices were the DK shares sold?

Weighted average prices were $41.42 for 17,000 shares and $41.25 for 10,000 shares, within disclosed ranges.

How many DK shares does the insider hold after the transactions?

The reporting person beneficially owns 23,020 shares directly after the reported sales.

Was the sale made under a 10b5-1 trading plan?

Yes. The transactions were made under a Rule 10b5-1 plan adopted on March 6, 2025 and amended on August 13, 2025.

What were the disclosed price ranges for the sales?

For the 17,000 shares: $41.39–$41.59. For the 10,000 shares: $41.16–$41.37.

Who is the reporting person’s role at Delek US (DK)?

The individual is an Officer serving as EVP, Special Projects.